20 LATEST RESOURCES (92 INDEXED)
Early versus Late Administration of Long-Acting Injectable Antipsychotic Agents among Patients with Newly Diagnosed Schizophrenia: An Analysis of a Commercial Claims Database · February 2023
Articles
International Clinical Psychopharmacology
Patterns of Antipsychotic Prescription and Accelerometer-Based Physical Activity Levels in People with Schizophrenia Spectrum Disorders: A Multicenter, Prospective Study · January 2023
Articles
International Clinical Psychopharmacology
Acceptability of Transdermal Antipsychotic Patches by Patients Who Refuse Oral Medication and Their Effectiveness in Preventing Recurrence of Delirium: A Retrospective Observational Study · January 2023
Articles
International Clinical Psychopharmacology
Clinical Correlates and Prognostic Impact of Binge-Eating Symptoms in Major Depressive Disorder · November 2022
Articles
International Clinical Psychopharmacology
The Dilemma of Polypharmacy in Psychosis: Is It Worth Combining Partial and Full Dopamine Modulation? · November 2022
Articles
International Clinical Psychopharmacology
Repeated Subcutaneous Racemic Ketamine in Treatment-Resistant Depression: Case Series · September 2022
Articles
International Clinical Psychopharmacology
Persistence of Suicidal Ideation within Acute Phase Treatment of Major Depressive Disorder: Analysis of Clinical Predictors · September 2022
Articles
International Clinical Psychopharmacology
Medicare Claims Analysis of Agents Used to Manage Dementia-Related Psychosis: A Treatment Pattern Study · May 2022
Articles
International Clinical Psychopharmacology
Effects of Acute Pain Medications on Posttraumatic Stress Symptoms in Early Aftermath of Trauma · May 2022
Articles (Manuscripts-Versions)
NCBI>International Clinical Psychopharmacology
Social Withdrawal as a Trans-Diagnostic Predictor of Short-Term Remission: A Meta-Analysis of Five Clinical Cohorts · March 2022
Articles
International Clinical Psychopharmacology
Efficacy and Safety of Lurasidone in Schizophrenia: Pooled Analysis of European Results from Double-Blind, Placebo-Controlled 6-Week Studies · March 2022
Articles
International Clinical Psychopharmacology
Vortioxetine Improves Cognition in Mild Cognitive Impairment · November 2021
Articles
International Clinical Psychopharmacology
Tolcapone in Obsessive Compulsive Disorder: A Randomized Double-Blind Placebo-Controlled Crossover Trial · September 2021
Articles (Manuscripts-Versions)
PubMed Central>International Clinical Psychopharmacology
Safety and Tolerability of Lumateperone for the Treatment of Schizophrenia: A Pooled Analysis of Late-Phase Placebo- and Active-Controlled Clinical Trials · May 2021
Articles
International Clinical Psychopharmacology
The Efficacy of Escitalopram in Major Depressive Disorder: A Multicenter Randomized, Placebo-Controlled Double-Blind Study · May 2021
Abstracts
International Clinical Psychopharmacology
The Effectiveness and Safety of Cariprazine in Schizophrenia Patients with Negative Symptoms and Insufficient Effectiveness of Previous Antipsychotic Therapy: An Observational Study · May 2021
Articles
International Clinical Psychopharmacology
Body Dysmorphic Disorder: A Treatment Synthesis and Consensus on Behalf of the International College of Obsessive-Compulsive Spectrum Disorders and the Obsessive Compulsive and Related Disorders Network of the European College of Neuropsychopharmacology · March 2021
Articles
International Clinical Psychopharmacology
Efficacy of Cariprazine in Bipolar I Depression Across Patient Characteristics: A Post Hoc Analysis of Pooled Randomized, Placebo-Controlled Studies · March 2021
Articles
International Clinical Psychopharmacology
Managing Dissociative Symptoms Following the Use of Esketamine Nasal Spray: A Case Report · January 2021
Articles
International Clinical Psychopharmacology
Effect of Pimavanserin on Anxious Depression in Patients with Major Depression and an Inadequate Response to Previous Therapy: Secondary Analysis of the Clarity Study · November 2020
Articles
International Clinical Psychopharmacology